Zai Lab Limited (HKG:9688)
14.16
-0.24 (-1.67%)
Jul 30, 2026, 2:15 PM HKT
Zai Lab Market Cap
Zai Lab has a market cap or net worth of 16.14 billion as of July 29, 2026. Its market cap has decreased by -54.12% in one year.
Market Cap
16.14B
Enterprise Value
12.77B
Revenue
3.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.16
ChartMarket Cap Chart
Since September 18, 2017, Zai Lab's market cap has increased from 1.36B to 16.14B, an increase of 1,087.52%. That is a compound annual growth rate of 32.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 16.14B | 5.66% |
| Dec 31, 2025 | 15.27B | -31.09% |
| Dec 31, 2024 | 22.16B | 5.54% |
| Dec 29, 2023 | 21.00B | -8.60% |
| Dec 30, 2022 | 22.97B | -51.38% |
| Dec 31, 2021 | 47.25B | -48.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Henlius Biotech | 30.44B |
| InnoCare Pharma | 28.47B |
| Keymed Biosciences | 24.25B |
| Duality Biotherapeutics | 20.56B |
| Ascentage Pharma Group International | 13.23B |
| Metis TechBio | 12.97B |
| GenFleet Therapeutics (Shanghai) | 12.29B |
| Nanjing Leads Biolabs | 11.55B |